You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / CE

Strategies for Improving Infection Control During Cancer Care

  • Authors: Douglas W. Blayney, MD; Janet Eagan, RN, MPH, CIC; Lisa C. Richardson, MD, MPH; Michele E. Gaguski, MSN, RN, AOCN, CHPN, APN-C
  • CME / CE Released: 10/30/2015
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 10/30/2016
Start Activity


Target Audience and Goal Statement

This activity is intended for oncologists, nurses, and other providers who care for patients undergoing cancer treatment and who may affect infection control practices.

The goals of this activity are to describe risk factors for neutropenia and infection in people with cancer, to discuss the policies and procedures that an outpatient oncology facility must follow to meet minimal expectations for protecting patients from infection as described in the Centers for Disease Control and Prevention's Basic Infection and Control Plan for Outpatient Oncology Settings (BICAPP), and to identify educational tools and resources that can help facilities implement infection control recommendations.

Upon completion of this activity, participants will be able to:

  1. Describe risk factors for neutropenia and infection in people with cancer
  2. Discuss the policies and procedures that an outpatient oncology setting must follow to meet the minimal expectations for protecting patients from infection as outlined in the Centers for Disease Control and Prevention's Basic Infection Control and Prevention Plan for Outpatient Oncology Settings (BICAPP)
  3. Identify educational tools and resources that can help facilities implement infection control practices


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Moderator

  • Douglas W. Blayney, MD

    Professor of Medicine (Oncology), Stanford University Medical Center; Member, Stanford Cancer Institute, Stanford, California

    Disclosures

    Disclosure: Douglas W. Blayney, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: AstraZeneca Pharmaceuticals LP; Bristol-Myers Squibb Company; CARET™/PRM; Hospira, Inc.; Pfizer Inc; United HealthCare Services, Inc.
    Owns stock, stock options, or bonds from: Abbott Cardiovascular Systems, Inc.; Amgen Inc.; Bristol-Myers Squibb Company; Express Scripts; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Medtronic, Inc.; United HealthCare Services, Inc.

    Dr. Blayney does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr. Blayney does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Panelists

  • Janet Eagan, RN, MPH, CIC

    Infection Control Manager, Memorial Sloan Kettering Cancer Center, New York, New York

    Disclosures

    Disclosure: Janet Eagan, RN, MPH, CIC, has disclosed no relevant financial relationships.

    Ms Eagan does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Ms Eagan does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

  • Michele E. Gaguski, MSN, RN, AOCN, CHPN, APN-C

    Clinical Director, Medical Oncology/Infusion Services, Atlanticare Cancer Care Institute, Egg Harbor Township, New Jersey

    Disclosures

    Disclosure: Michele E. Gaguski, MSN, RN, AOCN, CHPN, APN-C, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Panoramic Healthcare Communications

    Ms Gaguski does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Ms Gaguski does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

  • Lisa C. Richardson, MD, MPH

    Director, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia

    Disclosures

    Disclosure: Lisa C. Richardson, MD, MPH, has disclosed no relevant financial relationships.

    Dr Richardson does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Richardson does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editors

  • Margie Miller

    Lead Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Margie Miller has disclosed no relevant financial relationships.

  • Christin L. Melton

    Freelance editor, Kendall Park, New Jersey

    Disclosures

    Disclosure: Christin L. Melton has disclosed no relevant financial relationships.

Reviewer

  • Angela R. Dunbar

    Health Communications Specialist/CDC Foundation Fellow, CDC Foundation, Atlanta, Georgia

    Disclosures

    Disclosure: Angela R. Dunbar has disclosed no relevant financial relationships.

CME Reviewer/Nurse Planner

  • Amy Bernard, MS, BSN, RN-BC

    Lead Nurse Planner, Medscape, LLC

    Disclosures

    Disclosure: Amy Bernard, MS, BSN, RN-BC, has disclosed no relevant financial relationships.


Accreditation Statements

    For Physicians

  • Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    Contact This Provider

    For Nurses

  • Medscape, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    Awarded 0.50 contact hour(s) of continuing nursing education for RNs and APNs; none of these credits is in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / CE

Strategies for Improving Infection Control During Cancer Care

Authors: Douglas W. Blayney, MD; Janet Eagan, RN, MPH, CIC; Lisa C. Richardson, MD, MPH; Michele E. Gaguski, MSN, RN, AOCN, CHPN, APN-CFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME / CE Released: 10/30/2015

Valid for credit through: 10/30/2016

processing....

 

This feature requires the newest version of Flash. You can download it here.
  • Print